Internal Medicine Doctors in Reston, VA Accepting Medicare

86 Internal Medicine doctors found. Showing 81 - 86

Dr. Dhaval R Patel, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11800 Sunrise Valley Dr Ste 500, Reston, VA 20191 Phone: 703-437-5977    Fax: 703-478-2475

Dr. Radhika Gorantla Sharda, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-698-9000

Geoffrey Stewart Long, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1890 Metro Center Dr, Reston, VA 20190 Phone: 703-709-1500    Fax: 703-709-1697

Claude Abujrab-saba, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1860 Town Center Dr, 130, Reston, VA 20190 Phone: 703-709-9174    Fax: 703-709-9183

Sahana Hundal, Internal Medicine Medicare: Medicare Enrolled Practice Location: 11901 Baron Cameron Ave, Reston, VA 20190 Phone: 703-709-6116    Fax: 703-904-0497

Neil F Medoff, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11357 Sunset Hills Rd, Reston, VA 20190 Phone: 703-435-5858    Fax: 703-435-5877

News Archive

Maternal exposure to nanoparticles related to neurological dysfunction in the mouse

Maternal exposure to nanoparticles of titanium dioxide (TiO2) affects the expression of genes related to the central nervous system in developing mice. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that mice whose mothers were injected with the nanoparticles while pregnant showed alteration in gene expression related to neurological dysfunction.

Biomira files NDA for novel inhibitor of hypoxia-inducible factor-1 alpha

Biomira Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for PX-478. PX-478 has been shown in preclinical studies to inhibit hypoxia-inducible factor (HIF)-1 alpha, a protein that controls the transcription of a number of genes whose products are important for tumor growth and survival.

News outlets report on medical intellectual property developments, drug access issues

Inter Press Service reports on a recent symposium on access to medicine, "jointly hosted by the WHO, the World Trade Organization and the World Intellectual Property Organisation."

Chemotherapy drugs also kill malaria parasite

A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sant- et de la Recherche M-dicale, the French government agency for biomedical research) has discovered that a class of chemotherapy drugs originally designed to inhibit key signaling pathways in cancer cells also kills the parasite that causes malaria. The discovery could quickly open up a whole new strategy for combating this deadly disease.

Human embryonic stem cell, iPS-derived progeny are similar and developmentally immature

Stem cell researchers at UCLA have discovered that three types of cells derived from human embryonic stem cells and induced pluripotent stem cells are similar to each other, but are much more developmentally immature than previously thought when compared to those same cell types taken directly from human tissue.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3
• 4
• 5(current)